Patents Assigned to Levicept Limited
  • Therapeutic use of P75NTR neurotrophin binding protein
    Patent number: 12679880
    Abstract: Disclosed herein are therapeutic uses of p75NTR neurotrophin binding proteins and related molecules, such as fusion proteins comprising p75NTR neurotrophin binding proteins and immunoglobulin Fc or portions thereof, in the treatment of osteoarthritis.
    Type: Grant
    Filed: April 20, 2022
    Date of Patent: July 14, 2026
    Assignee: LEVICEPT LIMITED
    Inventor: Simon Westbrook
  • Therapeutic use of p75NTR neurotrophin binding protein
    Patent number: 11339202
    Abstract: The present invention relates to a new therapeutic use of a p75NTR neurotrophin binding protein and related molecules in the treatment of osteoarthritis.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: May 24, 2022
    Assignee: LEVICEPT LIMITED
    Inventor: Simon Westbrook
  • DNA molecule encoding a p75NTR(NBP)-Fc fusion protein
    Patent number: 10988526
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein (NBP)-Fc fusion protein comprising a p75NTR(NBP) portion and an immunoglobulin portion. In certain embodiments, the p75NTR(NBP)-Fc fusion protein is for use in the treatment of pain and/or a symptom of pain.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: April 27, 2021
    Assignee: Levicept Limited
    Inventor: Simon Westbrook
  • P75NTR binding protein-Fc fusion protein and methods of treating pain
    Patent number: 10683339
    Abstract: The present invention relates to a new p75NTR neurotrophin binding protein (NBP)-Fc fusion protein comprising a p75NTR (NBP) portion and an immunoglobulin portion. In certain embodiments, the p75NTR (NBP)-Fc fusion protein is for use in the treatment of pain and/or a symptom of pain.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: June 16, 2020
    Assignee: Levicept Limited
    Inventor: Simon Westbrook